Press Releases

Date Title and Summary  
Toggle Summary Geron Appoints Vice President, Pharmacovigilance and Drug Safety
MENLO PARK, Calif. , Jan. 17, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the hiring of the first of several key leadership positions as it rebuilds the in-house development team to support its plans to initiate a Phase 3 clinical trial of imetelstat in lower risk
Toggle Summary Geron Announces Expansion of Leadership Team with Appointment of Chief Medical Officer
Aleksandra Rizo , M.D., Ph.D., former clinical lead for the imetelstat program at Janssen, joins Geron as Chief Medical Officer Additional office to be opened in New Jersey to support expansion of clinical development team Preliminary operating expense guidance for 2019 provided MENLO PARK, Calif.